Deutsche Bank’s Tevogen Inc. Common Stock TVGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-15,324
Closed -$69.3K 3863
2026
Q1
$69.3K Buy
15,324
+11,849
+341% +$145K ﹤0.01% 3381
2025
Q4
$57.3K Buy
3,475
+2,615
+304% +$68K ﹤0.01% 3429
2025
Q3
$34K Buy
860
+151
+21% +$7.43K ﹤0.01% 3466
2025
Q2
$44.3K Buy
+709
New +$40.4K ﹤0.01% 3426
2023
Q4
Sell
-2
Closed -$1.08K 3717
2023
Q3
$1.08K Buy
+2
New +$1.08K ﹤0.01% 3659
2022
Q4
Sell
-5,000
Closed -$2.54M 4056
2022
Q3
$2.54M Sell
5,000
-800
-14% -$404K ﹤0.01% 1502
2022
Q2
$2.9M Hold
5,800
﹤0.01% 1561
2022
Q1
$2.9M Buy
+5,800
New +$2.88M ﹤0.01% 1679

Other funds holding TVGN

Deutsche Bank's TVGN Position: Q2 2026 in Review

Deutsche Bank sold out of Tevogen Inc. Common Stock (TVGN) in Q2 2026, closing a stake of 15,324 shares — an estimated $69.3K sold.

Deutsche Bank first reported a position in TVGN in Q1 2022 and held it in 8 quarters. The position peaked at $2.9M in Q2 2022. 11 funds tracked by Wall St. Rank hold TVGN as of Q2 2026.

  • Deutsche Bank reported no remaining Tevogen Inc. Common Stock position as of Q2 2026 after selling out during the quarter.
  • Deutsche Bank sold 15,324 Tevogen Inc. Common Stock shares in Q2 2026, an estimated $69.3K.
  • Deutsche Bank first reported a position in Tevogen Inc. Common Stock in Q1 2022 and held it in 8 quarters.
  • Deutsche Bank's Tevogen Inc. Common Stock position peaked at $2.9M in Q2 2022.
  • 11 funds tracked by Wall St. Rank held Tevogen Inc. Common Stock as of Q2 2026.

Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.